Clinical Trial Update: Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial of Oblimersen with doxorubicin and docetaxel in metastatic or locally advanced breast cancer; study terminated with results posted in 2012…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Doxorubicin (doxorubicin)
• Oblimersen (oblimersen)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Male Breast Cancer, Stage IIIA Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2012-08-16